These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 19088124)

  • 21. Crystallographic Studies of the Cerebral Cavernous Malformations Proteins.
    Fisher OS; Li X; Liu W; Zhang R; Boggon TJ
    Methods Mol Biol; 2020; 2152():291-302. PubMed ID: 32524560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ccm3 functions in a manner distinct from Ccm1 and Ccm2 in a zebrafish model of CCM vascular disease.
    Yoruk B; Gillers BS; Chi NC; Scott IC
    Dev Biol; 2012 Feb; 362(2):121-31. PubMed ID: 22182521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mural Cell-Specific Deletion of Cerebral Cavernous Malformation 3 in the Brain Induces Cerebral Cavernous Malformations.
    Wang K; Zhang H; He Y; Jiang Q; Tanaka Y; Park IH; Pober JS; Min W; Zhou HJ
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2171-2186. PubMed ID: 32640906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional analyses of human and zebrafish 18-amino acid in-frame deletion pave the way for domain mapping of the cerebral cavernous malformation 3 protein.
    Voss K; Stahl S; Hogan BM; Reinders J; Schleider E; Schulte-Merker S; Felbor U
    Hum Mutat; 2009 Jun; 30(6):1003-11. PubMed ID: 19370760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation analysis of CCM1, CCM2 and CCM3 genes in a cohort of Italian patients with cerebral cavernous malformation.
    D'Angelo R; Marini V; Rinaldi C; Origone P; Dorcaratto A; Avolio M; Goitre L; Forni M; Capra V; Alafaci C; Mareni C; Garrè C; Bramanti P; Sidoti A; Retta SF; Amato A
    Brain Pathol; 2011 Mar; 21(2):215-24. PubMed ID: 21029238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation prevalence of cerebral cavernous malformation genes in Spanish patients.
    Mondéjar R; Solano F; Rubio R; Delgado M; Pérez-Sempere A; González-Meneses A; Vendrell T; Izquierdo G; Martinez-Mir A; Lucas M
    PLoS One; 2014; 9(1):e86286. PubMed ID: 24466005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a c.601C>G mutation in the CCM1 gene in a kindred with multiple skin, spinal and cerebral cavernous malformations.
    Haghighi A; Fathi D; Shahbazi M; Motahari MM; Friedman B
    J Neurol Sci; 2013 Nov; 334(1-2):97-101. PubMed ID: 24007869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sporadic cerebral cavernous malformations: report of further mutations of CCM genes in 40 Italian patients.
    D'Angelo R; Alafaci C; Scimone C; Ruggeri A; Salpietro FM; Bramanti P; Tomasello F; Sidoti A
    Biomed Res Int; 2013; 2013():459253. PubMed ID: 24058906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Notch Signaling in Familial Cerebral Cavernous Malformations and Immunohistochemical Detection of Cleaved Notch1 Intracellular Domain.
    Hasan SS; Fischer A
    Methods Mol Biol; 2020; 2152():427-435. PubMed ID: 32524570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relevance of CCM gene polymorphisms for clinical management of sporadic cerebral cavernous malformations.
    Rinaldi C; Bramanti P; Scimone C; Donato L; Alafaci C; D'Angelo R; Sidoti A
    J Neurol Sci; 2017 Sep; 380():31-37. PubMed ID: 28870584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral cavernous malformation proteins at a glance.
    Draheim KM; Fisher OS; Boggon TJ; Calderwood DA
    J Cell Sci; 2014 Feb; 127(Pt 4):701-7. PubMed ID: 24481819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KLF4 is a key determinant in the development and progression of cerebral cavernous malformations.
    Cuttano R; Rudini N; Bravi L; Corada M; Giampietro C; Papa E; Morini MF; Maddaluno L; Baeyens N; Adams RH; Jain MK; Owens GK; Schwartz M; Lampugnani MG; Dejana E
    EMBO Mol Med; 2016 Jan; 8(1):6-24. PubMed ID: 26612856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation.
    Jenny Zhou H; Qin L; Zhang H; Tang W; Ji W; He Y; Liang X; Wang Z; Yuan Q; Vortmeyer A; Toomre D; Fuh G; Yan M; Kluger MS; Wu D; Min W
    Nat Med; 2016 Sep; 22(9):1033-1042. PubMed ID: 27548575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational analysis of CCM1, CCM2 and CCM3 in a Han Chinese cohort with multiple cerebral cavernous malformations in Taiwan.
    Jih KY; Chung CP; Chang YY; Hung PL; Soong BW; Liao YC; Lan MY; Lee YC
    Clin Genet; 2018 Oct; 94(3-4):389-390. PubMed ID: 29787619
    [No Abstract]   [Full Text] [Related]  

  • 35. Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype.
    Borikova AL; Dibble CF; Sciaky N; Welch CM; Abell AN; Bencharit S; Johnson GL
    J Biol Chem; 2010 Apr; 285(16):11760-4. PubMed ID: 20181950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent insights into cerebral cavernous malformations: the molecular genetics of CCM.
    Riant F; Bergametti F; Ayrignac X; Boulday G; Tournier-Lasserve E
    FEBS J; 2010 Mar; 277(5):1070-5. PubMed ID: 20096038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on Novel CCM Gene Mutations in Patients with Cerebral Cavernous Malformations.
    Scimone C; Bramanti P; Alafaci C; Granata F; Piva F; Rinaldi C; Donato L; Greco F; Sidoti A; D'Angelo R
    J Mol Neurosci; 2017 Feb; 61(2):189-198. PubMed ID: 28000143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cerebral cavernous malformations proteins.
    Li X; Fisher OS; Boggon TJ
    Oncotarget; 2015 Oct; 6(32):32279-80. PubMed ID: 26356566
    [No Abstract]   [Full Text] [Related]  

  • 39. Predictive genetic testing of at-risk relatives requires analysis of all CCM genes after identification of an unclassified CCM1 variant in an individual affected with cerebral cavernous malformations.
    Schröder W; Najm J; Spiegler S; Mair M; Viera J; Henn W; Felbor U
    Neurosurg Rev; 2014 Jan; 37(1):161-5. PubMed ID: 23722637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defective autophagy is a key feature of cerebral cavernous malformations.
    Marchi S; Corricelli M; Trapani E; Bravi L; Pittaro A; Delle Monache S; Ferroni L; Patergnani S; Missiroli S; Goitre L; Trabalzini L; Rimessi A; Giorgi C; Zavan B; Cassoni P; Dejana E; Retta SF; Pinton P
    EMBO Mol Med; 2015 Nov; 7(11):1403-17. PubMed ID: 26417067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.